Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.

NCT00854867 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumour Neoplastic Meningitis
Brain Metastases

Interventions

DRUG: Whole Brain Radio Therapy (WBRT) with sequential Depocyte
DRUG: Whole brain radiotherapy (WBRT) with concomitant Depocyte

Sponsor

Mundipharma Research Limited